Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Zito Marino, F"'
Autor:
Rossi G, Jocollé G, Conti A, Tiseo M, Zito Marino F, Donati G, Franco R, Bono F, Barbisan F, Facchinetti F
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 8, Pp 45-55 (2017)
Giulio Rossi,1 Genny Jocollé,2 Antonia Conti,3 Marcello Tiseo,4 Federica Zito Marino,5,6 Giovanni Donati,7 Renato Franco,5,6 Francesca Bono,8 Francesca Barbisan,9 Francesco Facchinetti4,10 1Pathology Unit, 2Oncology Unit, Azienda USL Valle d’Aosta
Externí odkaz:
https://doaj.org/article/a1ba6c03f55d443a8bc0cfe41a8f2e7e
Autor:
Pagliuca F., Zito Marino F., Morgillo F., della Corte C., Santini M., Vicidomini G., Guggino G., de Dominicis G., Campione S., Accardo M., Cozzolino I., Franco R.
Publikováno v:
European review for medical and pharmacological sciences. 25(12)
– Malignant mesothelioma (MM) is a rare aggressive neoplasm arising from mesothelial lining of body cavities, most commonly pleura and peritoneum. It is characterised by a poor prognosis and limited treatment options. A universally recognised risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0df5a12b157e3ba6deb74d3d9b53fba4
https://pubmed.ncbi.nlm.nih.gov/34227091
https://pubmed.ncbi.nlm.nih.gov/34227091
Autor:
Zito Marino F., Rossi G., Cozzolino I., Montella M., Micheli M., Bogina G., Munari E., Brunelli M., Franco R., ZITO MARINO, Federica
Publikováno v:
Journal of Clinical Pathology. 73:96-101
AimsSeveral predictive biomarkers of response to specific inhibitors have become mandatory for the therapeutic choice in non-small-cell lung cancer (NSCLC). In most lung cancer patients, the biological materials available to morphological and molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079b7e26f2189b3756ef214a76754346
https://doi.org/10.1136/jclinpath-2019-206152
https://doi.org/10.1136/jclinpath-2019-206152
Autor:
Montella M., Franco R., Aquino G., Ronchi A., Zito Marino F., Di Napoli M., Pignata S., Cozzolino I., ZITO MARINO, Federica
Publikováno v:
Diagnostic cytopathologyREFERENCES. 49(1)
Background: Renal cell carcinoma (RCC) constitutes 3% of all cancers, with a higher incidence in patients with age between 60 and 70 years. RCC frequently present as a metastatic tumor at diagnosis, and bones represent one of the most frequent sites.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0307056badce38cbb01af5d202f61a7
https://pubmed.ncbi.nlm.nih.gov/32809251
https://pubmed.ncbi.nlm.nih.gov/32809251
Autor:
Ronchi A., Montella M., Cozzolino I., Argenziano G., Moscarella E., Piccolo V., Iovino F., Troiani T., Alfano R., Errico M. E., D'Onofrio V., Berretta M., Franco R., Zito Marino F., ZITO MARINO, Federica
Publikováno v:
European review for medical and pharmacological sciences. 24(7)
OBJECTIVE: Anaplastic lymphoma kinase (ALK) gene has been demonstrated to be rearranged, mutated or amplified in several haematological and solid tumors. Moreover, the use of ALK inhibitors has recently revolutionized the treatment of ALK-rearranged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::245508b397b7100348a87298595e7ba5
https://pubmed.ncbi.nlm.nih.gov/32329859
https://pubmed.ncbi.nlm.nih.gov/32329859
Autor:
Pagliuca F., Ronchi A., Cozzolino I., Montella M., Zito Marino F., Franco R., ZITO MARINO, Federica
Publikováno v:
Pathology, research and practice. 216(6)
Soft tissue tumors comprise a great variety of common and rare entities with overlapping features. Their diagnosis is based on the evaluation of several histological parameters which are difficult to assess on small incisional biopsies. Useful diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada4e94f3ff478486d8c88c1a88a7652
https://pubmed.ncbi.nlm.nih.gov/32303388
https://pubmed.ncbi.nlm.nih.gov/32303388
Autor:
Ronchi A., Pagliuca F., Zito Marino F., Accardo M., Cozzolino I., Franco R., ZITO MARINO, Federica
Publikováno v:
Seminars in cancer biology. 72
The identification of biomarkers on cancer tissue samples could be obtained through several technologies. In this setting, the immunohistochemistry and in situ hybridization are accessible in most pathology laboratories. Particularly, immunohistochem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd18a7e0d5acc7e1121aa614b8d2aef9
https://pubmed.ncbi.nlm.nih.gov/32165319
https://pubmed.ncbi.nlm.nih.gov/32165319
Autor:
Cardone C., Blauensteiner B., Moreno-Viedma V., Martini G., Simeon V., Vitiello P. P., Ciardiello D., Belli V., Matrone N., Troiani T., Morgillo F., Zito Marino F., Dentice M., Nappi A., Boccaccino A., Antoniotti C., Cremolini C., Pietrantonio F., Prager G. W., Normanno N., Maiello E., Argiles G., Elez E., Signoriello G., Franco R., Falcone A., Tabernero J., Sibilia M., Ciardiello F., Martinelli E., ZITO MARINO, Federica
Background RAS mutations are the only validated biomarkers in metastatic colorectal cancer (mCRC) for anti-epidermal growth factor receptor (EGFR) therapy. Limited clinical information is available on AXL expression, marker of epithelial to mesenchym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4937b3b9337afc85a90006c6268b2a74
https://hdl.handle.net/11588/920571
https://hdl.handle.net/11588/920571
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martini, G., Troiani, T., Ciardiello, D., Napolitano, S., Famiglietti, V., Arrichiello, G., Esposito, L., Franco, R., Zito Marino, F., Panarese, I., Cardone, C., Maiello, E., Latiano, T.P., Avallone, A., Vitiello, P.P., Mariella, E., Reginelli, A., Ciardiello, F., Martinelli, E.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S444-S444